Subcutaneous vs. intramuscular testosterone injections
Updated August 2026 · Both routes are used in testosterone replacement therapy. Here is how they differ, what research suggests, and how the right one is chosen for you.
The short answer
Testosterone injections can be given intramuscularly (IM) — into a muscle — or subcutaneously (SubQ) — into the layer of fat just under the skin. Published studies in men treated for confirmed testosterone deficiency generally report that both routes can achieve appropriate testosterone levels. The practical differences are in needle size, comfort, technique, and how steady blood levels stay between doses. Neither route is best for everyone; the choice is made with your clinician and then confirmed with follow-up lab work.
How each route works
Intramuscular injection is the traditional route and the one most testosterone products, including testosterone cypionate, are FDA-labeled for. The medication is injected into a larger muscle — usually the thigh or buttock — where it forms a depot and is absorbed over days. IM injections typically use a 1 to 1.5-inch needle at 22 to 25 gauge.
Subcutaneous injection delivers the same medication into the fat of the abdomen or thigh with a much shorter, finer needle — commonly 25 to 31 gauge and about half an inch or shorter. Absorption from fat is somewhat slower and, in some studies, produces smaller peaks and troughs between doses. One testosterone enanthate auto-injector (Xyosted) is FDA-approved specifically for weekly subcutaneous use; subcutaneous use of testosterone cypionate is a common off-label practice supported by published studies.
What the research suggests
Comparative studies and clinical experience generally report that subcutaneous testosterone injection can produce total testosterone levels comparable to intramuscular injection at similar doses, with low pain scores and steadier levels between injections for some patients. The intramuscular route has the longer track record and remains the labeled route for most formulations. As with most questions in hormone therapy, the evidence does not crown a single winner — it supports individualizing the route and verifying the result with lab work rather than assuming it.
Side-by-side comparison
| Intramuscular (IM) | Subcutaneous (SubQ) | |
|---|---|---|
| Injection site | Thigh or buttock muscle | Abdominal or thigh fat |
| Typical needle | 1–1.5 inch, 22–25 gauge | ≤ 5/8 inch, 25–31 gauge |
| Regulatory status | Labeled route for most testosterone products | FDA-approved for one auto-injector; common off-label route for cypionate |
| Common site effects | Next-day muscle soreness | Temporary redness, itching, or small lumps |
| Level pattern | Well characterized; larger peak-to-trough swings for some patients | Steadier levels between doses reported in some studies |
| Self-injection | Learnable; longer needle deters some patients | Often easier to learn and continue |
Practical differences patients notice
- Comfort. The shorter, finer SubQ needle does not enter muscle, and many patients find it easier — though site reactions like temporary lumps or itching are more common with SubQ, and some patients simply prefer how IM feels.
- Technique and rotation. Both routes require sterile technique and rotating injection sites. SubQ technique is generally simpler to learn for self-injection at home.
- Dosing schedule. Either route is commonly dosed weekly or split twice-weekly. Schedule and dose are set by your clinician and adjusted from lab results and symptoms, not by the route alone.
- Monitoring is identical. Whichever route you use, treatment is monitored the same way — levels, hematocrit, symptoms, and side effects are reviewed on the schedule your care plan specifies.
How the right route is chosen
At Ignite HRT, injection route is part of the treatment conversation, not a default. It depends on the formulation prescribed, your dose, body composition, comfort with self-injection, and how your levels respond — which is verified with follow-up lab work rather than assumed. Route changes are likewise made with your clinician, since the same dose can behave differently by route. Delivery options beyond injections (pellets, gels and patches, intranasal) are covered on the men's TRT page.
Frequently asked questions
Is subcutaneous testosterone as effective as intramuscular?
Published studies in men treated for confirmed testosterone deficiency generally report that subcutaneous injection can achieve total testosterone levels comparable to intramuscular injection, and one testosterone enanthate auto-injector is FDA-approved specifically for subcutaneous use. Individual response varies, so levels are confirmed with lab work after any change in route or dose rather than assumed.
Do subcutaneous injections hurt less than intramuscular?
Many patients find subcutaneous injections more comfortable because the needle is shorter and finer and does not enter muscle, and studies report low pain scores with the subcutaneous route. Comfort is individual: subcutaneous injections can cause temporary redness, itching, or small firm lumps at the site, while intramuscular injections more often cause next-day muscle soreness.
What needle is used for a subcutaneous testosterone injection?
Subcutaneous injections typically use a short, fine needle — commonly 25 to 31 gauge and about half an inch (13 mm) or shorter — into the fat of the abdomen or thigh. Intramuscular injections typically use a longer needle, commonly 1 to 1.5 inches and 22 to 25 gauge, to reach the muscle of the thigh or buttock. The clinic teaches the specific supplies and technique for the option prescribed to you.
Can testosterone cypionate be given subcutaneously?
Testosterone cypionate is FDA-labeled for intramuscular injection, and clinicians in the United States commonly prescribe it subcutaneously as an off-label route supported by published studies. Whether that is appropriate in your case is a clinical decision made with your prescriber and confirmed with follow-up lab work.
Can I switch from intramuscular to subcutaneous injections?
Sometimes, but not on your own. Route changes are made with your clinician, because the injection route can affect how the same dose behaves; levels and symptoms are rechecked after a switch. If you are an Ignite HRT patient and want to discuss your injection route, bring it up at any visit or message the clinic.
Talk it through with a clinician
Ignite HRT is an in-person TRT clinic serving the Portland metro from Gresham and Beaverton, Oregon. Evaluation, blood draws, injection teaching, and monitoring all happen at the clinic with one clinician responsible for your care. Read about the men's TRT program or book a free 15-minute informational call.
This guide is educational and is not a substitute for professional medical advice, diagnosis, or treatment. Injection route, dose, and schedule are individual clinical decisions made with your prescriber.